|
Begleiter, Asher; Norman, Alia; Leitao, Darren et al. (2005) Role of NQO1 polymorphisms as risk factors for squamous cell carcinoma of the head and neck. Oral Oncol 41:927-33
|
|
Han, Yusheng; Shen, Hongmei; Carr, Brian I et al. (2004) NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors. J Pharmacol Exp Ther 309:64-70
|
|
Pan, Su-Shu; Han, Yusheng; Farabaugh, Philip et al. (2002) Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T. Pharmacogenetics 12:479-88
|
|
Begleiterabc, A; Leith, M K; Doherty, G P et al. (2001) Factors influencing the induction of DT-diaphorase activity by 1,2-dithiole-3-thione in human tumor cell lines. Biochem Pharmacol 61:955-64
|
|
Li, Y; Eiseman, J L; Sentz, D L et al. (1996) Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1,12-diaziridinyl-4,9-diazadodecane. J Med Chem 39:339-41
|
|
Hu, L T; Stamberg, J; Pan, S (1996) The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C. Cancer Res 56:5253-9
|
